おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
LensGen
company
About
LensGen creates adaptive intraocular lenses for the treatment of presbyopia.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $10M
- Industries
- Health Care,Medical,Medical Device
- Founded date
- Aug 1, 2011
- Number Of Employee
- 51 - 100
- Operating Status
- Active
LensGen is an ophthalmic medical device company that has developed a biomimetic, curvature changing fluid-optic intraocular lens designed for the treatment of cataracts and presbyopia. It offers Juvene™ which is designed to fit inside the same location as the natural human lens and adjusts dioptric power on demand through curvature change by using the same tiny muscle contractions that occur within the eye.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$31M
LensGen has raised a total of
$31M
in funding over 2 rounds. Their latest funding was raised on
Aug 20, 2020 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 20, 2020 | Series Unknown | $10M | 1 |
Hoya Corporate Venture Capital Group
|
— | Detail |
| May 1, 2017 | Series A | $21M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
LensGen is funded by 2 investors.
Hoya Corporate Venture Capital Group
and Relativity Healthcare Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Hoya Corporate Venture Capital Group
|
Yes | Series Unknown |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
